A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Bipolar Disorders
Trial Locations (45)

Unknown

Research Site, Aarschot

Research Site, Afsnee

Research Site, Antwerp

Research Site, Asse

Research Site, Berchem

Research Site, Bertrix

Research Site, Bierbeek

Research Site, Bouge

Research Site, Bruges

Research Site, Brussels

Research Site, Dave

Research Site, Dendermonde

Research Site, Erpe Mere

Research Site, Geel

Research Site, Ghent

Research Site, Hasselt

Research Site, Ixelles-Elsene

Research Site, Kortenberg

Research Site, Kortrijk

Research Site, Laken

Research Site, Lebbeke

Research Site, Lede

Research Site, Leuven

Research Site, Libramont

Research Site, Lierneux

Research Site, Liège

Research Site, Lubbeek

Research Site, Malle

Research Site, Marchienne-au-Pont

Research Site, Mons

Research Site, Montignies-sur-Sambre

Research Site, Namur

Research Site, Ottignies

Research Site, Roselaere

Research Site, Saint Denijs Westrem

Research Site, Saint-Servais

Research Site, Sint-Josse-ten-Noode

Research Site, Sint-Martens-Latem

Research Site, Sint-Niklaas

Research Site, Sleidinge

Research Site, St-Truiden

Research Site, Tienen

Research Site, Tournai

Research Site, Zottegem

Research Site, Zoutleeuw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY